An elongate flattened thermoplastic tube has an inflation edge and an opposite edge. The tube includes spaced transverse seals that define sides of pouches. The tube includes lines of weakness that allow adjacent dunnage units to be separated. A frangible line of connection is disposed in one two superposed layers of the tube proximate to the inflation edge. This frangible connection may be broken to permit inflation of the inflatable pouches.

A flexible inside corner trim piece is formed with concave depressions at hinge portions where wings attach to the body. The trim piece can be formed such that wings and a top cap lay flat in plane perpendicular to body or wings and top cap curve at an angle. Hinge portions can be narrow or wide and symmetrical or asymmetrical. The trim piece can be dyed, paintable, or present another decorative surface. The trim piece can include embedded lighting.

A packaging sheet is described. The sheet comprises a first rigid component, a second rigid component, and a multilayer film. Each of the first rigid component and the second rigid component comprises styrenic polymer, aromatic polyester, aliphatic polyester, polypropylene homopolymer, or blends thereof. The multilayer film is a blown, coextruded film positioned between the first rigid component and the second rigid component and comprises (a) an outer layer, (b) a barrier component, and (c) an inner layer, where the barrier component is positioned between the outer layer and the inner layer. The first rigid component is coated on or laminated to a first surface of the multilayer film and the second rigid component is coated on or laminated to an opposing second surface of the multilayer film such that the sheet is not a fully coextruded sheet. Various embodiments of the sheet are also described.

A sealed pharmaceutical container includes a shoulder, a neck extending from the shoulder, and a flange extending from the neck. The flange includes an inclined sealing surface defining an opening in the sealed pharmaceutical container. The sealed pharmaceutical container also includes a sealing assembly including a stopper extending over the sealing surface of the flange and a cap securing the stopper to the flange. The stopper has a glass transition temperature (T.sub.g) that is greater than or equal to −70° C. and less than or equal to −45° C. The sealing assembly maintains a helium leakage rate of the sealed pharmaceutical container of less than or equal to 1.4×10.sup.−6 cm.sup.3/s as the sealed pharmaceutical container is cooled to a temperature of less than or equal to −45° C.

Embodiments are directed to systems and methods for two or more cured composite assemblies that are bonded together to form a tubular composite structure, wherein each of the cured composite assemblies do not have a tubular shape. The tubular composite structure may form a spar for an aerodynamic component, for example. The two or more cured composite assemblies may comprise carbon or fiberglass composite materials or a combination of materials. Each of the cured composite assemblies may further comprise axial edges that are configured to be bonded to another of the cured composite assemblies, wherein the axial edges have a sloped shape. An adhesive agent may be applied on the axial edges for bonding two cured composite assemblies. Alternatively, or additionally, one or more fasteners may be used to attach the axial edges of at least two cured composite assemblies.

The invention provides metal liquid chromatography components with uniformly coated internal surfaces and methods for achieving the same. The invention addresses the problem of corrosion or interference of metal components in the flow path for LC analyses in which the sample interacts with metal ions or surfaces. The invention also alleviates the difficulties in coating very long metal tubes and very small metal channels with an inert, continuous coating that adheres well to metal surfaces. The metal flow path is rendered inert by the coating, and thus compatible with bioanalytical separations, for example, by using a vapor phase deposition process to coat the inner surfaces with a coating that continuously covers all metal surfaces in the flow path.

A quartz glass container is shown and described herein. The quartz glass container exhibits a low concentration of surface defects on an inner surface of the container. In aspects hereof, the container may have a surface defect density of 50 or fewer surface defects per square centimeter within a 1 cm band centered 1 cm from the base of the container.

The present invention concerns fixed dosing of HER antibodies, such as Pertuzumab.

Multi-layer films for making bags for containing flowable materials, in particular to large bags for dairy products. The multi-layer films have an outer and an inner sealant layer and a core layer and optionally, an interposed layer positioned between the outer sealant layer and the core layer and between the core layer and the inner sealant layer. The outer and inner sealant layers contain an ethylene/α-olefin interpolymer composition and the intermediate layer optionally contains this interpolymer composition.

The invention is directed to a polymeric film web, a carrier film, and a magnetic member. The carrier film comprises an inner polyethylene terephthalate layer and an outer plastomer layer. The magnetic member and the carrier film are layered onto the polymeric film web to form a closure member. The outer plastomer layer is adjacent the magnetic member and the carrier film extends beyond an upper edge and/or a lower edge of the magnetic member. The closure is heat sealed such that the seal at the interface of the first carrier film and the second carrier film is a peelable seal, the seal at the interface of the first film web and the first carrier film is a permanent seal, and the seal at the interface of the second film web and the second carrier film is a permanent seal.